Company Filing History:
Years Active: 2014
Title: Innovations of Philippe Fernades in Pharmaceutical Chemistry
Introduction
Philippe Fernades is a notable inventor based in Sunderland, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of purine derivatives. His work focuses on compounds that exhibit excellent anti-tumor activity, which has important implications for cancer treatment.
Latest Patents
Fernades holds 1 patent for his invention titled "Crystalline forms of a purine derivative." This patent describes new crystalline forms that serve as active ingredients in pharmaceutical compositions. The invention not only details the anti-tumor properties of these compounds but also outlines a process for their preparation, showcasing Fernades' innovative approach to drug development.
Career Highlights
Philippe Fernades is associated with Cyclacel Limited, a company that specializes in the development of innovative cancer therapies. His work at Cyclacel has positioned him as a key player in the pharmaceutical industry, contributing to advancements in cancer treatment through his research and inventions.
Collaborations
Fernades has collaborated with notable colleagues, including Benjamin Mark Skead and Christopher Peter Worrall. These partnerships have enhanced the research and development efforts at Cyclacel Limited, fostering an environment of innovation and scientific discovery.
Conclusion
Philippe Fernades is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact cancer treatment significantly. His innovative contributions, particularly in the development of purine derivatives, highlight the importance of research in advancing medical science.